FDA: "FDA approves ground breaking gene therapy to deal with pediatric patients with spinal muscular atrophy, a exceptional condition and leading genetic reason behind infant mortality," "FDA approves to start with drug for spinal muscular atrophy." This informative article is in regards to the genetic dysfunction connected to the SMN1 http://ruangankerja.id/